Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations are in order for Departmental Research Lecturer Dr Mootaz Salman who has been awarded a prestigious Early Career Fellowship funded by the Leverhulme Trust.

Mootaz Salman profileDr Mootaz Salman has been awarded a Leverhulme Trust Early Career Fellowship - a highly prestigious, fiercely competitive research award with just 145 awards available nationally this year across all disciplines. These fellowships enable early career academics to undertake a significant piece of publishable work.

Dr Salman is now pursuing a 3-year research project entitled “Targeting mechanisms of blood-brain barrier dysfunction in Parkinson’s using humanized 3D brain-on-a-chip models”, on which he will work independently within DPAG in close collaboration with the Wade-Martins Group.

Dr Salman intends to target the blood–brain barrier (BBB), which tightly regulates the brain microenvironment, and is known to be instrumental in the progression of Parkinson’s. The fellowship will allow him to develop an innovative dynamic 3D multicellular in vitro model to accurately recapitulate the BBB under Parkinson’s-associated inflammatory conditions using human-derived induced pluripotent stem cells (iPSCs).

Dr Salman said: “This model will allow the incorporation of blood flow under different pressures to accurately model hypertension, which is a major risk factor for dementia. I will use this system to define the mechanisms involved in BBB leakiness and identify new drug targets for early intervention in neurodegeneration.”

“I am honoured to receive this generous funding from the Leverhulme Trust to investigate an important area of research in which the aggregate societal cost of which is £3.3 billion/year in the UK, with a total annual economic burden of £20,000 per household. Parkinson’s is currently an incurable condition and the precise mechanism underlying its pathophysiology is not fully understood. Targeting the BBB is an exciting approach which might help in preventing the disease or slowing its onset significantly”.

“My ultimate aim is to reduce the burden to relatives, care providers and the NHS, and more importantly alleviate everyday suffering in patients.”

More information about the fellowship can be found on the Leverhulme Trust website.

Similar stories

Mootaz Salman set to target new treatments for stroke

The Chief Scientist Office of the Government of Scotland has awarded a collaborative grant of £298,966 to Dr Mootaz Salman to seek new therapeutic avenues to treat stroke.

Gero Miesenböck awarded 2023 Japan Prize

Congratulations are in order for Professor Gero Miesenböck, who has been awarded the 2023 Japan Prize in the field of Life Sciences, together with Professor Karl Deisseroth, for pioneering work in the field of optogenetics.

Mootaz Salman receives prestigious science award from Iraq

Congratulations are in order for Dr Mootaz Salman, who has received the National Medal of Distinctive Scientific Achievement by the Government of Iraq.

Professor Denis Noble awarded the Lomonosov Gold Medal

The Russian Academy of Sciences has awarded its highest accolade, the Lomonosov Gold Medal, to Emeritus Professor Denis Noble CBE, FRS.

Professor Dame Frances Ashcroft awarded the Manpei Suzuki International Prize for Diabetes Research

The 2022 Manpei Suzuki International Prize for Diabetes Research recognises original and excellent achievements in diabetes research. Professor Ashcroft is the first women to win in the 15 years this prestigious Prize has been awarded.